Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Managing the Benign Hematology Consult: Treatment Recommendations fo…

Indy Hematology Review

C. Kessler

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

Management of Hematologic Conditions in Athletes

Scripps Health

R. Kasthuri

Gene Therapy for Sickle Cell Disease: Are We Where They Wanted Us to…

Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

A. Sharma

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Exercises in CBC Interpretation: Sickle Cell Anemia

The Blood Project

N. Bavli

Sickle Cell Disease 101

Cayenne Wellness 15th Annual Hybrid Sickle Cell Disease Educational Summit

I. Osunkwo

Hematologic Emergencies

Michigan Medicine

A. Ahmed

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

Updates in Therapeutics for Sickle Cell Disease

University of Colorado Division of Hematology

G. George

ASH 2023 Summary: "Updates in Hereditary TTP and Sickle Cell Disease"

BMFcases

I. Ibrahim, T. Bat, Y. Shen

ATS 2023 Insights: Airway Function in Sickle Cell Disease: Impact on…

ATS 2023 Insights

S. Willen

ASH 2022: What's Hot in Sickle Cell Disease Research 2022

ASH 2022 Conference Coverage

E. Klings

Conference Highlights: Opioids in Medically Complex Patients - Old C…

2024 Conference Highlights

A. Mishkin